As a pharmaceutical biotechnology research company we focus on the discovery and development of modern and innovative cannabinoid medical therapies and medicines to treat diseases that have been ailing patients worldwide. Our belief that medicinal marijuana can help treat these diseases is backed by our extensive research from our dedicated team of individuals that have been in this branch of science for most of their professional lives.
Merlin Biotechnologies researches and develops marijuana-based therapeutic products through modern bio-technology from the marijuana plant which has a clinically proven multitude of healing properties and benefits to the human body.
Our research is only focused on the naturally-occurring cannabinoids so that our results not only offers clinically proven relief and treatment to the patient, but also affords them clinically approved use which will afford a more natural form of treatment when compared to the current alternatives that are available in the market today.
We aim to take the quality of patient care to the next level by becoming the most specialist biotechnology pharmaceutical research and development company focused on cannabinoids and cannabinoid drug delivery systems. Our goal is to transform lives by developing safe and effective medicinal marijuana treatments across a multitude of diseases, some of which have long running unmet medical needs.
We intend to accomplish this by focusing our research and development on all available cannabinoid compounds as there are specific and unique cannabinoid compounds that are beneficial to specific diseases. Many of these therapies are already available in the market but we aim to develop more to cover those diseases that have medicinal needs that have not been addressed.
Together with our many partner companies, from those that produce the plant, through to the hospitals and healthcare professionals who prescribe the medication, our research and development is never far from discovering new treatments and cures.
We are extremely selective in respect to the companies that we decide to partner with, which is why as a group we will always strive to create change in the medical industry by removing misconceptions about marijuana therapy. Our team is highly motivated to move forward and be aggressive in our research and development to provide the best quality products available in the market worldwide. We believe that when our goals are met, we will create a safer world where marijuana-based medicines are easily available to treat and heal diseases that are considered as incurable today.
Our company started out as a biotechnology research company but has now grown in to not only providing research, but now also developing and producing cannabinoid-based treatments. The successful growth of our organization has proven that when the common goal that we all share is to help improve human lives, our success has followed these set goals.
Our partners, consumers and investors trust in our commitment is at the core of our success, and this is why our company has been able to achieve sustained growth and stability. We have built a great portfolio that offers not only proven research but also a seamless partnership process in developing these products. This alone has created and generated a great sense of value to our patients and shareholders alike.
We have successfully established several subsidiaries that are primarily engaged in the development of natural health products which contain cannabinoids as their main ingredient, as well as other medicinal plant-based elements. While ourselves and other global pharmaceutical companies have helped secure approval for marijuana derivatives, nobody has yet proven to regulators that almost all marijuana-based products have their own unique medical benefits.
This is why we will not only focus our efforts on research and development, but we also aim to educate the entire medical profession about the potential that medicinal marijuana has to help cure diseases.
Merlin Biotechnologies dedicates significant time and capital in to its scientific research and development programs which help ensure a continuous and sustainable pipeline of products based on patient needs. We have already seen how many of our products help patients with their symptoms, and is why we believe that our goals and objectives are very important in the pharmaceutical sector.
We are always innovating and we are currently undertaking a number of clinical research programs to further study new treatments that can be derived from the marijuana plant.
More countries and U.S. states are now in full agreement of the benefits that medicinal marijuana affords and, as a result, now allowing the legal use and sale of medical marijuana products. More individuals and the broader medical community are also recognizing these potential benefits too, driving higher demand for medicinal marijuana.
We are developing a novel and unique class of product that targets hard to treat or incurable diseases. Our research has already contributed in several effective medicinal treatments now being on the market. And the success of our research only motivates us to move forward and discover new therapies and cures.
If you would like to become part of our success story too, please feel free to visit our Investor Relations page.
At Merlin Biotechnologies our entire team’s philosophy ensures that we are unwavering in our commitment to bring the best scientific research and marijuana-based treatments to doctors and patients worldwide.
As one of the first analytical laboratories dedicated to the clinical research of medical marijuana in Canada, we have led the science of marijuana medication since 2014. During that time, Merlin Biotechnologies has made market changing discoveries, such as High-CBD genetic markers, and pioneered the implementation of self-regulation throughout the medical marijuana industry.
Today, our expanded philosophy has resulted in us employing sophisticated technology and rigorous science to solve more of today’s medical health problems: whether you are cultivating, processing, or even dispensing – our philosophy is to help you diagnose and solve potential problems to ensure an optimum working procedure in your work flow.
By investing in groundbreaking research, technologies and medical platforms, we aim to drive our innovative philosophy within our pipeline and deliver better solutions to the medical profession and their patients. We are currently exploring several new methods for delivering medicines in a more precise and impactful manner. Whether it be a way to reduce the effect of chemotherapy on healthy cells or to opening new avenues for treating neurodegenerative diseases, our research and clinical innovation will soon change the way diseases are treated.
At Merlin Biotechnologies, we're driven by a deep affection for scientific exploration and research. Our lab does not simply quantify cannabinoid profiles, or assess the sex of living plants, we also discover new truths in the realms and possibilities of marijuana research and treatments.
As our research and development programs increase so does our philosophical expertise, transforming breakthrough science into effective medicine. Tomorrow’s innovations are always researched and developed by today’s entrepreneurs, and because of this we invest in transformational scientific opportunities that are aligned with our core research and development interests. This ensures we gain access to next-generation science and build relationships with proven and emerging scientific leaders.
If you would like to become part of our success story too, please feel free to visit our Investor Relations page.
Overall, there are more than 85 unique cannabinoid compounds found in the plant. The most important of them are namely THC and CBD, both of which are found in the marijuana plant, and both of which are the major components in the global medicinal use of marijuana today, despite each of these compounds having completely different effects.
THC creates a psychoactive ‘high’ when a person ingests it via smoking or cooked edibles. This is because THC breaks down when heat is applied to it and then introduced into the body, while CBD is different. Unlike THC, CBD is not psychoactive.
CBD will not change a person's state of mind when they use it and they will only benefit from the clinically proven medicinal properties of CBD’s healing effects.
All cannabinoids occur naturally in the marijuana plant although it was not until recently that scientists have established proven research, and with it a greater understanding, of the many different cannabinoids along with their respective therapeutic and medicinal benefits.
One of the major cannabinoids derived from marijuana is Cannabidiolic acid. This cannabinoid is part of one of current research programs for its anticonvulsant properties as a potential treatment for schizophrenia, as well as other neurological conditions.
Cannabinoids can now be taken into the body in many different ways, by inhalation of smoke or vapor, as an aerosol spray into the cheek, by gels and creams, by tinctures, by mouth and our recent partnership with an Israeli company developed a precise dosage method by use with an inhaler.
CBD may be also supplied as an oil, containing only certain CBD strains as its active ingredient to treat certain conditions. In the United States, the cannabidiol drug Epidiolex has been approved by the Food and Drug Administration, (FED), as the first marijuana-based drug approved by them and is successfully used for the treatment of two epilepsy disorders, Lennox-Gastaut syndrome and Dravet syndrome.
THC is one of the major cannabinoids found in marijuana. It was discovered in the 1960’s by Raphael Mechoulam and along with CBD it is one of the most well-known cannabinoids in the world.
People have been medicating themselves with medical cannabis for over 3000 years. However, since the 1920’s it became restricted in many countries.
Some governments claim that marijuana is a gateway drug that will lead to the consumer experimenting with more harmful substances, although research has proven that this is not the case and that marijuana is a lot less harmful to the body than alcohol.
Through the years, THC has been known for its mind-altering properties, but research now shows that it too has important medicinal benefits.
There is now some clinically proven overlap in what CBD and THC can treat, but THC is particularly effective in relieving nausea, appetite loss, insomnia, among other symptoms.
Many patients find that a balance of CBD and THC offers the best symptom relief as the two work together synergistically.
Increases appetite: One of the most common therapeutic effects of THC is that it is able to stimulate the appetite of those with eating disorders such as anorexia or with diseases such as cancer and HIV.
Relieves nausea and vomiting: Since the 1980’s there have been pills that have been prescribed to cancer patients that contain THC, they help to reduce the side effects of chemotherapy such as nausea and vomiting.
Post-traumatic stress disorder: THC causes interference between the interaction and processing of information within the hippocampus, the site in our brain where memories are formed. This effect helps to reduce the amount of flashbacks PTSD sufferers have.
Relieves Chronic pain: The analgesic effects of THC is one of its main therapeutic properties. For those who struggle with chronic pain related to inflammation or not, THC is an effective pain reliever because it works with the body’s endocannabinoid system, which controls and regulates pain and inflammation.
As compared to traditional pharmaceutical painkillers., THC in marijuana is much safer, more natural, and non-addictive than conventional pharmaceutical medication.
Mental-Health Conditions: Tetrahydrocannabinol is a versatile and useful compound, especially regarding the treatment of mental conditions like depression, anxiety, alcoholism, and other addictions.
According to modern case reports, marijuana has been shown to be very effective in treating withdrawal symptoms from alcohol, opiate, and benzodiazepine dependencies. And the usage of THC is beneficial for depression and anxiety, with the right strain and dosage.
Hybrid strains are of course ideal when treating mental health diseases/conditions.
Digestive Problems: Another benefit of THC is its ability to provide patients suffering from digestive problems relief. For example, people suffering from Crohn’s disease or diabetes, it has been proven that THC gives them relief to their digestive pain, spasms and discomfort.
Anti- Oxidant: In the human brain, cannabinoids act as anti-oxidants, which reduces ‘glutamate toxicity’, this is good because glutamate serves as a neurotransmitter that signals nerve cells to fire. Too much glutamate could cause nerve overstimulation, but the cannabinoids help protect the brain’s cells from damage thanks to the anti-oxidants in THC.